| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/28/2005 | EP1608684A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 12/28/2005 | EP1608682A2 Plant haemoglobin |
| 12/28/2005 | EP1608679A1 Dystrophin-related protein (drop1), a marker for carcinomas |
| 12/28/2005 | EP1608676A2 Nontypeable haemophilus influenzae virulence factors |
| 12/28/2005 | EP1608672A2 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
| 12/28/2005 | EP1608410A2 Pharmico-gene theraphy of epithelial sodium channel associated disoders |
| 12/28/2005 | EP1608409A2 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/28/2005 | EP1608404A2 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 12/28/2005 | EP1608393A2 Ebola peptides and immunogenic compositions containing same |
| 12/28/2005 | EP1608384A2 Therapy for primary and metastatic cancers |
| 12/28/2005 | EP1608355A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases |
| 12/28/2005 | EP1608320A2 Novel imidazoline receptor homologs |
| 12/28/2005 | EP1608307A2 An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
| 12/28/2005 | EP1608219A2 Integrase mediated avian transgenesis |
| 12/28/2005 | EP1585822A4 Promoter variants for expressing genes in a fungal cell |
| 12/28/2005 | EP1581904A3 Novel proteins with altered immunogenicity |
| 12/28/2005 | EP1579000A4 Magnetism based nucleic acid amplification |
| 12/28/2005 | EP1516056A4 Thioesterase-related nucleic acid sequences and methods of use for the production of plants with modified fatty acid composition |
| 12/28/2005 | EP1507852A4 Nucleic acids and proteins with thioredoxin reductase activity |
| 12/28/2005 | EP1504096A4 Seed specific usp promoters for expressing genes in plants |
| 12/28/2005 | EP1497455A4 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 12/28/2005 | EP1492804B1 Process for isolating nucleic acid with chaotrope agents and ammonium compounds |
| 12/28/2005 | EP1490013A4 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea |
| 12/28/2005 | EP1485503A4 Improved nucleic acid amplification |
| 12/28/2005 | EP1478760A4 Esterases with lipase activity |
| 12/28/2005 | EP1478386A4 Method for drying water-borne materials |
| 12/28/2005 | EP1456394A4 Methods of using improved polymerases |
| 12/28/2005 | EP1453979A4 Multiplex pcr |
| 12/28/2005 | EP1432450B1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 12/28/2005 | EP1427852A4 Single nucleotide amplification and detection by polymerase |
| 12/28/2005 | EP1421213A4 Labeled nucleoside polyphosphates |
| 12/28/2005 | EP1406482A4 Cotton event moni5985 and compositions and methods for detection |
| 12/28/2005 | EP1379539A4 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 12/28/2005 | EP1364029B1 FUSION PROTEIN comprising hirudin and proinsulin or insulin |
| 12/28/2005 | EP1335987B1 Modified vaccinia ankara virus variant |
| 12/28/2005 | EP1326597B1 Use of kcnq potassium channel agonists for the manufacture of a medicament for modulating bladder function |
| 12/28/2005 | EP1315806B1 Method for screening highly active proteases and inhibitors |
| 12/28/2005 | EP1284597A4 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots, maize, rice and wheat plants resistant to the imidazolinone herbicides |
| 12/28/2005 | EP1278834B1 Process for complex nucleic acid analysis |
| 12/28/2005 | EP1221482B1 Hemopoietin receptor protein, nr12 |
| 12/28/2005 | EP1161561B1 One step sample preparation and detection of nucleic acids in complex biological samples |
| 12/28/2005 | EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides |
| 12/28/2005 | EP1073683B1 G-csf receptor agonist antibodies and screening method therefor |
| 12/28/2005 | EP1066033B1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 12/28/2005 | EP1029920B1 Alkaline protease |
| 12/28/2005 | EP1025240B1 Multiply-substituted protease variants with altered net charge for use in detergents |
| 12/28/2005 | EP1025227B1 Human toll homologues |
| 12/28/2005 | EP1025129B1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan |
| 12/28/2005 | EP1021544B1 Chimeric vaccine against tick-borne encephalitis virus |
| 12/28/2005 | EP1011717B1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
| 12/28/2005 | EP0971959B1 Humanized antibodies and methods for forming humanized antibodies |
| 12/28/2005 | EP0953642B1 Antigenic protein originating in infectious laryngotracheitis virus |
| 12/28/2005 | EP0940467B1 Promoters for swine complement inhibitors |
| 12/28/2005 | EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 12/28/2005 | EP0920534B1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) hnf-1alpha, hnf-1beta and hnf-4alpha |
| 12/28/2005 | EP0920448B1 Truncated glial cell line-derived neurotrophic factor |
| 12/28/2005 | EP0879281B1 Methods for transforming dendritic cells and activating t cells |
| 12/28/2005 | EP0859840B1 Biologically active eph family ligands |
| 12/28/2005 | EP0797676B1 Recombinant adenoviral vector and methods of use |
| 12/28/2005 | EP0797589B1 Peptides usable as vectors for the intracellular addressing of active molecules |
| 12/28/2005 | EP0787186B1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 12/28/2005 | EP0742834B9 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 12/28/2005 | EP0682529B2 Antibody for the treatment of insulin dependent diabetes |
| 12/28/2005 | EP0672159B1 Homologous sequence targeting in eukaryotic cells |
| 12/28/2005 | EP0662134B1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof |
| 12/28/2005 | EP0652964B1 K. lactis transaldolase gene promoter and use thereof |
| 12/28/2005 | EP0646175B1 Recombinant pseudomonas exotoxin with increased activity |
| 12/28/2005 | EP0642585B1 Activation of oligomerizing receptors by using fused receptor ligands |
| 12/28/2005 | CN1714153A Recombinant protein variants |
| 12/28/2005 | CN1714152A Aspartyl protease inhibitor as a nematode allergen |
| 12/28/2005 | CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 12/28/2005 | CN1714149A Strain belonging to the genus streptomyces and being capable of producing nemadictin and process for producing nemadictin using the strain |
| 12/28/2005 | CN1714148A Viral deconstruction through capsid assembly in vitro |
| 12/28/2005 | CN1714145A High sensitivity quantitation of peptides by mass spectrometry |
| 12/28/2005 | CN1712537A Culture of indica rice tran-gene tree from agrobacterium medium |
| 12/28/2005 | CN1712536A Expression of interleukin 24 from yeast cell |
| 12/28/2005 | CN1712535A Carrier structure and use for transfection cell separation containing CD34 labelled gene |
| 12/28/2005 | CN1712534A Nucleic acid structure and expression carrier for enhancing recombinant protein production and mass-production of recombinant protein |
| 12/28/2005 | CN1712533A Superhalophilic antient bacteria plasmid and its derivative plasmid carrier |
| 12/28/2005 | CN1712532A Pig tyraminase beta protein coding sequence |
| 12/28/2005 | CN1712531A High-molecular glutelin By8 gene of flint wheat and use thereof |
| 12/28/2005 | CN1712530A Method for removing selective labelled gene in genetic plant |
| 12/28/2005 | CN1712529A Chimeric virus particle vaccine carrier protein, its production and use |
| 12/28/2005 | CN1712415A Connexin transduction structural domain and bioactive protein of auxiliary protein, its production and use |
| 12/28/2005 | CN1233838C Sequence resolving technology related to gene structure and function research |
| 12/28/2005 | CN1233833C Method for breeding salt-resistant tomato utilizing atriplex hortensis BADH gene transfer |
| 12/28/2005 | CN1233832C Microbiological method for producing L-carnitine |
| 12/28/2005 | CN1233831C SiRNA and expression plasmid for inhibiting human bc1-2 gene expression and their use for preparing medicine |
| 12/28/2005 | CN1233830C China bee and hornet hemolysis peptide precursor gene and coded polypeptide and preparing method |
| 12/28/2005 | CN1233829C New technique for preparing STR allelomorphic gene stairs and kit possessing the stairs |
| 12/28/2005 | CN1233828C Antihuman hemoglobin detection reagent strips and monoclone antibody contained therewith |
| 12/28/2005 | CN1233827C Method of point mutation without need of chain reaction of polymerase and the kit |
| 12/28/2005 | CN1233826C Reformed lactase of Pichia pastoris and its application |
| 12/28/2005 | CN1233825C Wheat stem antilaid grain related caffeic acid methyl transferase, gene of coding said enzyme and expression carrier containing said gene |
| 12/28/2005 | CN1233823C Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage |
| 12/28/2005 | CN1233822C Interleukin-15 gene modified natural killing cell strain and its preparation method |
| 12/28/2005 | CN1233820C Bacterial host strains |
| 12/28/2005 | CN1233819C Red sea bacillus and its separating and culturing method and fermentation technology and use |
| 12/28/2005 | CN1233816C Recombinant yeast strain and IFN alpha-la interferon purifying process |
| 12/28/2005 | CN1233659C Human granulocyte-macrophage colony stimulating factor/interleukin-6 fusion protein and its construction process |